Cargando…
Strategies to sensitize cancer cells to immunotherapy
Recent years have seen the emergence of immunotherapy as a promising modality for treating a variety of cancers. However, the initial data have led to the ultimate reality that such a treatment does not work effectively in all cancers, nor does it universally result in long-lasting benefits, which c...
Autores principales: | George, Andrew, Sahin, Ilyas, Carneiro, Benedito A., Dizon, Don S., Safran, Howard P., El-Deiry, Wafik S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475577/ https://www.ncbi.nlm.nih.gov/pubmed/34019474 http://dx.doi.org/10.1080/21645515.2021.1891817 |
Ejemplares similares
-
AMG-232 sensitizes high MDM2-expressing tumor cells to T-cell-mediated killing
por: Sahin, Ilyas, et al.
Publicado: (2020) -
Correction: AMG-232 sensitizes high MDM2-expressing tumor cells to T-cell-mediated killing
por: Sahin, Ilyas, et al.
Publicado: (2020) -
Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response
por: De Souza, Andre, et al.
Publicado: (2020) -
Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers
por: Carlsen, Lindsey, et al.
Publicado: (2022) -
ROS1-GOPC/FIG: a novel gene fusion in hepatic angiosarcoma
por: Marks, Eric I., et al.
Publicado: (2019)